126 related articles for article (PubMed ID: 22706535)
41. Fludarabine for chronic lymphocytic leukemia.
Copur MS; Ledakis P; Muhvic J
N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302141
[No Abstract] [Full Text] [Related]
42. Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma.
Hendry L; Bowen A; Matutes E; Swansbury J; Catovsky D
Leuk Lymphoma; 2004 May; 45(5):945-50. PubMed ID: 15291353
[TBL] [Abstract][Full Text] [Related]
43. Fludarabine phosphate as an active and well tolerated salvage therapy in an elderly heavily pretreated Hodgkin's disease patient: a case report.
Bordonaro R; Ferraù F; Giuffrida D; Calì S; Priolo D; Colina P; Ursino M; Failla G
Tumori; 1999; 85(4):288-9. PubMed ID: 10587034
[TBL] [Abstract][Full Text] [Related]
44. Fludarabine-induced eosinophilia: case report.
Voutsadakis IA
Ann Hematol; 2002 May; 81(5):292-3. PubMed ID: 12029541
[TBL] [Abstract][Full Text] [Related]
45. Synchronous Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly and Epstein-Barr virus-positive classical Hodgkin lymphoma.
Hwang YY; Leung AY; Lau WH; Loong F; So JC; Tse E; Kwong YL
Histopathology; 2011 Aug; 59(2):352-5. PubMed ID: 21884219
[No Abstract] [Full Text] [Related]
46. [A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].
Lü SQ; Yang JM; Song XM; Chen L; Zhang WP; Ni X; Xu XQ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):710-2. PubMed ID: 18246806
[TBL] [Abstract][Full Text] [Related]
47. Pleomorphic medium-sized T-cell lymphoma following Hodgkin's disease (nodular sclerosis type).
Gaulier A; Teillet F; Davi F; Couturier J; Laye S; Raphael M
Arch Pathol Lab Med; 1997 Apr; 121(4):411-6. PubMed ID: 9140313
[TBL] [Abstract][Full Text] [Related]
48. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.
Hochster HS; Kim KM; Green MD; Mann RB; Neiman RS; Oken MM; Cassileth PA; Stott P; Ritch P; O'Connell MJ
J Clin Oncol; 1992 Jan; 10(1):28-32. PubMed ID: 1727921
[TBL] [Abstract][Full Text] [Related]
49. Progressive multifocal leukoencephalopathy shortly after the diagnosis of follicular lymphoma in a patient treated with fludarabine.
Rodríguez L; Ribera JM; Batlle M; Xicoy B; Mate JL; Millá F; Feliu E
Haematologica; 2002 Jul; 87(7):ECR26. PubMed ID: 12091141
[No Abstract] [Full Text] [Related]
50. Presence of Epstein-Barr virus in non-Hodgkin's lymphomas arising in patients treated for Hodgkin's disease.
Khan G; Norton AJ; Slavin G
Int J Cancer; 1993 Feb; 53(3):529-30. PubMed ID: 8381398
[No Abstract] [Full Text] [Related]
51. Reversible acute renal failure following single administration of fludarabine.
Nunes R; Passos-Coelho JL; Miranda N; Nave M; da Costa FL; Abecasis M
Bone Marrow Transplant; 2004 Mar; 33(6):671. PubMed ID: 14730341
[No Abstract] [Full Text] [Related]
52. Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
Rai KR; Freter CE; Mercier RJ; Cooper MR; Mitchell BS; Stadtmauer EA; Santábarbara P; Wacker B; Brettman L
J Clin Oncol; 2002 Sep; 20(18):3891-7. PubMed ID: 12228210
[TBL] [Abstract][Full Text] [Related]
53. Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia.
Miyata A; Kojima K; Yoshino T; Fujii S; Shinagawa K; Ichimura K
Int J Hematol; 2001 Feb; 73(2):230-5. PubMed ID: 11372737
[TBL] [Abstract][Full Text] [Related]
54. Oral fludarabine: a viewpoint by Dieter Huhn.
Huhn D
Drugs; 2003; 63(21):2324. PubMed ID: 14524734
[No Abstract] [Full Text] [Related]
55. Hodgkin's disease in a child with acute lymphoblastic leukemia.
Kim HS; Roh HO; Kang SH; Lyu CJ; Kim KY; Hong SW; Yang WI
Yonsei Med J; 1991 Sep; 32(3):270-4. PubMed ID: 1781187
[TBL] [Abstract][Full Text] [Related]
56. Reversible neurologic toxicity in patients treated with standard-dose fludarabine phosphate for mycosis fungoides and chronic lymphocytic leukemia.
Cohen RB; Abdallah JM; Gray JR; Foss F
Ann Intern Med; 1993 Jan; 118(2):114-6. PubMed ID: 8416307
[No Abstract] [Full Text] [Related]
57. Another case of myelodysplasia with monosomy 7 following fludarabine-based chemotherapy.
Murphy PT; Mitra S; O'Donghaile D
Am J Hematol; 2006 Jun; 81(6):473. PubMed ID: 16680754
[No Abstract] [Full Text] [Related]
58. Fludarabine-related myeloid leukemia.
Astrow AB
J Clin Oncol; 2003 Oct; 21(19):3709; author reply 3709-10. PubMed ID: 14512411
[No Abstract] [Full Text] [Related]
59. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease.
Kingma DW; Medeiros LJ; Barletta J; Raffeld M; Mann RB; Ambinder RF; Jaffe ES
Am J Surg Pathol; 1994 Jan; 18(1):48-61. PubMed ID: 8279628
[TBL] [Abstract][Full Text] [Related]
60. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
